Sharay
Latest round
- Series B
Last raised
- Jul 2023
Total raised
- $14M
Investors
- 3
About Sharay
Founded in 2018 and based in Chengdu, China, Sharay is a biotech company that focuses on the research and development of core raw materials for in vitro diagnostic reagents. In 2020, the company obtained 29 NMPA registration certificates. It has a research and development center in Suzhou and industrial platforms in Sichuan and Hunan. The company's main product is a fully automatic chemiluminescence analyzer. It also offers autoimmune testing, allergen testing, cytokine testing, and thrombosis testing.
Who invested in Sharay
3 investors across 2 rounds
See all investors in Sharay
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sharay
Who invested in Sharay?
Sharay has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sharay raised?
Sharay has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sharay last raise money?
Sharay's most recent round on record is a Series B, in Jul 2023.
What does Sharay do?
Founded in 2018 and based in Chengdu, China, Sharay is a biotech company that focuses on the research and development of core raw materials for in vitro diagnostic reagents.
Where is Sharay headquartered?
Sharay is headquartered in Chengdu, China.
Which VCs invest in companies like Sharay?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Sharay's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sharay? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.